logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Østfold Hospital Kalnes

+4769860000
noraad@so-hf.no
Source: Site record.
http://www.sykehuset-ostfold.no

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Østfold Hospital Kalnes (Sykehuset Østfold Kalnes) is a state-of-the-art, 89,000-square-meter specialist healthcare facility serving over 300,000 residents of Østfold County. Inaugurated by King Harald V on November 30, 2015, following a budget of over NOK 6 billion, the complex was designed by Arkitema Architects and partners using advanced digital 3D modeling. It was constructed under Norway’s innovative "health house" model, which utilizes healing architecture, sound insulation, and layout design to reduce patient length of stay, optimize staff workflow, and promote recovery.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Government hospital

Business Subcategory

Source: Google. Government hospital
Source: Google. Hospital
Source: Trial-derived.
33Total Trials
Source: Trial-derived.
9Recruiting Trials
Source: Trial-derived.
10Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
72Unique Conditions
Source: Trial-derived.
63Unique Sponsors

Conditions

Source: Trial-derived. Venous Thromboembolism (3)Source: Trial-derived. Deep Venous Thrombosis (2)Source: Trial-derived. Heart Failure (2)Source: Trial-derived. Influenza (2)Source: Trial-derived. Pulmonary Embolism (2)Source: Trial-derived. Purpura, Thrombocytopenic, Idiopathic (2)Source: Trial-derived. Acute Non-cardioembolic Ischemic Stroke (1)Source: Trial-derived. Advance Care Planning (1)

Sponsors

Source: Trial-derived. Ostfold Hospital Trust (11)Source: Trial-derived. Oslo University Hospital (6)Source: Trial-derived. University Hospital, Akershus (6)Source: Trial-derived. Boehringer Ingelheim (4)Source: Trial-derived. Haukeland University Hospital (4)Source: Trial-derived. St. Olavs Hospital (3)Source: Trial-derived. University Hospital of North Norway (3)Source: Trial-derived. University of Oslo (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom